The vote follows World Health Organization guidance saying that due to cannabis’ therapeutic use and other factors, it “is not consistent with the criteria” for a Schedule IV drug.
(Image credit: Luke Dray/Getty Images)
The vote follows World Health Organization guidance saying that due to cannabis’ therapeutic use and other factors, it “is not consistent with the criteria” for a Schedule IV drug.